Researchers group of Cima and Clínica University of Navarra (IMAGE)
Caption
Researchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myeloma and primary systemic amyloidosis with a better prognosis because they have a more benign profile. This tool, designed in collaboration with the Spanish Myeloma Group (GEM-PETHEMA), could become part of the diagnostic workup of these patients.
Credit
Manuel Castells. Cima University of Navarra
Usage Restrictions
No restrictions.
License
Public Domain